Advisortrust Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Advisortrust Partners's LLY Position: Q2 2026 in Review
Advisortrust Partners increased its Eli Lilly (LLY) stake by 6.7% in Q2 2026, buying an estimated $95K and bringing the position to 1,473 shares worth $1.77M. The position accounts for 0.6% of the portfolio, ranked #37.
Advisortrust Partners first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Advisortrust Partners held 1,473 shares of Eli Lilly worth $1.77M as of Q2 2026.
- Advisortrust Partners bought 93 Eli Lilly shares in Q2 2026, an estimated $95K.
- Eli Lilly made up 0.6% of Advisortrust Partners's portfolio in Q2 2026, its #37 holding.
- Advisortrust Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
- 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Advisortrust Partners's 13F filing for Q2 2026, filed 10 Aug 2026.